-
Verastem Oncology Provides a Clinical Update for RAMP 203 Trial in Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
18 Dec 2024 12:41 GMT
… mutant advanced non-small cell lung cancer (NSCLC). No dose-limiting … G12C mutant non-small cell lung cancer.”
RAMP 203 Clinical Update … G12C mutant non-small cell lung cancer (NSCLC) who have not … with gemcitabine/nab-paclitaxel in patients with front-line …
-
FDA Grants Jemperli Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
21 Dec 2024 23:42 GMT
… therapies for gynecologic, colorectal and lung cancers. This proves an important task … in combination with carboplatin and paclitaxel, followed by Jemperli as a …
-
Incyte Announces Positive Results from Phase 3 Trial Evaluating Retifanlimab (Zynyz®) in Combination with Platinum-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer
07 Dec 2024 12:42 GMT
… metastatic non-small cell lung cancer (NSCLC) not … Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer … , accounting for approximately 85% of all lung cancer … NSCLC, and with paclitaxel and carboplatin for squamous …
-
AstraZeneca's Imfinzi receives US FDA approval to treat patients with limited─stage small cell lung cancer
06 Dec 2024 04:06 GMT
… extensive-stage small cell lung cancer, underscoring our commitment … chemotherapy (carboplatin and paclitaxel) followed by Imfinzi … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond …
-
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
05 Dec 2024 12:23 GMT
… Notes
Small cell lung cancer
Lung cancer is the leading … chemotherapy (carboplatin and paclitaxel) followed by IMFINZI … for people with lung cancer, including and beyond … lung-cancer-101/types-of-lung-cancer.
American Cancer Society. Small cell lung cancer …
-
FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations
03 Dec 2024 11:55 GMT
… and Taiwan).
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … and either paclitaxel or paclitaxel protein-bound, … and either paclitaxel or paclitaxel protein-bound …
-
Analysis of the Effects of Bevacizumab Combined with Chemoradiotherapy on VEGF, bFGF, and Let-7 Levels in Non-Small Cell Lung Cancer and the Factors Influencing Therapeutic Efficacy: A Retrospective Cohort Study
02 Dec 2024 18:59 GMT
… subtypes, non-small cell lung cancer (NSCLC) predominates, … lung cancer and induce cell cycle arrest of lung cancer … JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, … atezolizumab plus bevacizumab, paclitaxel and carboplatin for first …
-
Low-dose chemotherapy combined with delayed immunotherapy in the neoadjuvant treatment of non-small cell lung cancer and dynamic monitoring of the drug response in peripheral blood
26 Nov 2024 21:53 GMT
… platinum-based chemotherapy: albumin-bound paclitaxel 180-220 mg/m2 … P2. NSCLC, non-small cell lung cancer; TCR, T-cell receptor; ctDNA … -5 days) after chemotherapy in lung cancer patients may be more effective …
-
Afatinib Combined with Bevacizumab in the Treatment of Patients with Non-Small Cell Lung Cancer Harboring EGFR G719X, S768I or L861Q/P Mutations
25 Nov 2024 11:17 GMT
… oncogenic drivers in lung cancers to select targeted drugs … al. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma. N … with non-small cell lung cancer. Lung Cancer. 2015;87(2): … cell lung cancer: new evidence and treatment. Transl Lung Cancer Res. …
-
Advances in the Treatment of Rare Mutations in Non-Small Cell Lung Cancer
20 Nov 2024 07:57 GMT
… small cell lung cancer (NSCLC) and small cell lung cancer (SCLC … compared to standard paclitaxel-based chemotherapy.84 … -small cell lung cancer; SCLC, small cell lung cancer; EGFR, epidermal … Receptor Kinase Fusion-Positive Lung Cancers. JCO Precis Oncol …
About
© 1995-2024